サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：組み換えタンパク質製造サービスの世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）
市場調査レポート
商品コード
1377879

組み換えタンパク質製造サービスの世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）

Global Recombinant Proteins Manufacturing Services Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030
出版日: | 発行: Value Market Research | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
組み換えタンパク質製造サービスの世界市場：産業分析、規模、シェア、成長、動向、予測（2023～2030年）
出版日: 2023年09月01日
発行: Value Market Research
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の組み換えタンパク質製造サービスの市場規模は、2022年に42億9,000万米ドルとなり、2023～2030年にかけてCAGR 18.29%で成長し、2030年には約164億5,000万米ドルに達する見込みです。

組み換えタンパク質製造サービスとは、バイオテクノロジーや製造受託機関（CMO）が、様々な目的のために組換えタンパク質を製造するために提供するプロセスや施設を指します。組換えタンパク質は、遺伝子工学的に生物（一般的には細菌、酵母、哺乳類細胞、あるいは植物）を操作し、目的とする特定のタンパク質を発現させることによって生産されます。これらのタンパク質は、医薬品、バイオテクノロジー、研究、診断、工業用途など、様々な分野で使用されています。

市場力学

組み換えタンパク質製造サービス市場は、いくつかの重要な要因により成長を遂げています。モノクローナル抗体やワクチンのような生物学的製剤の需要に牽引されるバイオ医薬品産業の拡大は、主要な促進要因です。生物学的製剤は様々な疾患の治療に使用されるようになっており、組換えタンパク質の生産が必要となっています。ライフサイエンスとバイオテクノロジーの研究開発活動、遺伝子工学の進歩、受託製造のアウトソーシング動向が需要をさらに押し上げています。慢性疾患の有病率の上昇、COVID-19によって強調されたパンデミックへの備えの必要性、タンパク質発現および精製技術における継続的な技術進歩が市場の成長に寄与しています。規制当局の承認、特にバイオ医薬品セクターでは、信頼性が高くコンプライアンスに準拠した製造サービスへの需要が確実なものとなっています。新興市場とサービスプロバイダーが提供するカスタマイズオプションも一役買っています。

調査レポートは、ポーターのファイブフォースモデル、市場魅力度分析、バリューチェーン分析をカバーしています。これらのツールは、業界の構造を明確に把握し、世界レベルでの競合の魅力を評価するのに役立ちます。さらに、これらのツールは、組み換えタンパク質製造サービスの世界市場における各セグメントを包括的に評価することもできます。組み換えタンパク質製造サービス産業の成長と動向は、この研究に全体的なアプローチを提供します。

地域分析

このセクションでは、北米、欧州、アジア太平洋、ラテンアメリカ、中東・アフリカにおける組み換えタンパク質製造サービス市場の現在と将来の需要を強調する地域展望をカバーしています。さらに、本レポートでは、すべての主要地域における個々のアプリケーションセグメントの需要、推定・予測に焦点を当てています。

目次

第1章 序文

第2章 エグゼクティブサマリー

  • 市場のハイライト
  • 世界市場スナップショット

第3章 組み換えタンパク質製造サービス - 産業分析

  • イントロダクション - 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 業界動向
  • ポーターのファイブフォース分析
  • 市場魅力度分析

第4章 バリューチェーン分析

  • バリューチェーン分析
  • 原材料分析
    • 原材料リスト
    • 原材料メーカーリスト
    • 主要原材料の価格動向
  • 潜在的バイヤーのリスト
  • マーケティングチャネル
    • ダイレクトマーケティング
    • インダイレクトマーケティング
    • マーケティングチャネル発展動向

第5章 組み換えタンパク質製造サービスの世界市場分析：サービスタイプ別

  • サービスタイプ別概要
  • 実績データと予測データ
  • サービスタイプ別分析
  • 前臨床・臨床サービス
  • 商業生産サービス

第6章 組み換えタンパク質製造サービスの世界市場分析：宿主細胞別

  • 宿主細胞別概要
  • 実績データと予測データ
  • 宿主細胞別分析
  • 哺乳類細胞
  • 細菌細胞
  • 昆虫細胞
  • 酵母・真菌
  • その他

第7章 組み換えタンパク質製造サービスの世界市場分析：エンドユーザー別

  • エンドユーザー別概要
  • 実績データと予測データ
  • エンドユーザー別分析
  • 製薬・バイオテクノロジー企業
  • 学術・研究機関

第8章 組み換えタンパク質製造サービスの世界市場分析：地域別

  • 地域別展望
  • イントロダクション
  • 北米売上分析
    • 概要、実績と予測
    • 北米：セグメント別
    • 北米：国別
    • 米国
    • カナダ
    • メキシコ
  • 欧州売上分析
    • 概要、実績と予測
    • 欧州：セグメント別
    • 欧州：国別
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • ロシア
    • その他の欧州
  • アジア太平洋売上分析
    • 概要、実績と予測
    • アジア太平洋：セグメント別
    • アジア太平洋：国別
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • 東南アジア
    • その他のアジア太平洋
  • ラテンアメリカ売上分析
    • 概要、実績と予測
    • ラテンアメリカ：セグメント別
    • ラテンアメリカ：国別
    • ブラジル
    • アルゼンチン
    • ペルー
    • チリ
    • その他のラテンアメリカ
  • 中東・アフリカ売上分析
    • 概要、実績と予測
    • 中東・アフリカ：セグメント別
    • 中東・アフリカ：国別
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他の中東・アフリカ

第9章 組み換えタンパク質製造サービス企業の競合情勢

  • 組み換えタンパク質製造サービス市場の競合
  • 提携・協力・合意
  • 合併・買収
  • 新製品上市
  • その他の開発

第10章 企業プロファイル

  • 企業シェア分析
  • 市場集中度
  • Lonza
  • Boehringer Ingelheim International GmbH
  • FUJIFILM Diosynth Biotechnologies
  • Merck KGaA
  • Bruker（InVivo BioTech Services GmbH）
  • Sino Biological Inc.
  • GenScript
  • Kaneka Corporation（Kaneka Eurogentec S.A）
  • Polyplus Transfection（Xpress Biologics）
  • Boster Biological Technology
  • Trenzyme GmbH
図表

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Service Type (USD MN)
  • Pre-Clinical & Clinical Services Market Sales by Geography (USD MN)
  • Commercial Production Services Market Sales by Geography (USD MN)
  • Analysis Market by Host Cell (USD MN)
  • Mammalian Cells Market Sales by Geography (USD MN)
  • Bacterial Cells Market Sales by Geography (USD MN)
  • Insect Cells Market Sales by Geography (USD MN)
  • Yeast & Fungi Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by End-User (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Global Recombinant Proteins Manufacturing Services Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Recombinant Proteins Manufacturing Services Report
  • Market Research Process
  • Market Research Methodology
  • Global Recombinant Proteins Manufacturing Services Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Service Type
  • Market Attractiveness Analysis by Host Cell
  • Market Attractiveness Analysis by End-User
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Service Type (USD MN)
  • Pre-Clinical & Clinical Services Market Sales by Geography (USD MN)
  • Commercial Production Services Market Sales by Geography (USD MN)
  • Global Market Analysis by Host Cell (USD MN)
  • Mammalian Cells Market Sales by Geography (USD MN)
  • Bacterial Cells Market Sales by Geography (USD MN)
  • Insect Cells Market Sales by Geography (USD MN)
  • Yeast & Fungi Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by End-User (USD MN)
  • Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
  • Academic & Research Institutes Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

目次
Product Code: VMR112112237

The global demand for Recombinant Proteins Manufacturing Services Market is presumed to reach the market size of nearly USD 16.45 BN by 2030 from USD 4.29 BN in 2022 with a CAGR of 18.29% under the study period 2023 - 2030.

Recombinant protein manufacturing services refer to the processes and facilities offered by biotechnology and contract manufacturing organizations (CMOs) to produce recombinant proteins for various purposes. Recombinant proteins are produced by genetically engineering organisms, typically bacteria, yeast, mammalian cells, or even plants, to express specific proteins of interest. These proteins are used in various fields, including pharmaceuticals, biotechnology, research, diagnostics, and industrial applications.

MARKET DYNAMICS:

The recombinant proteins manufacturing services market is experiencing growth due to several key factors. The expansion of the biopharmaceutical industry, driven by the demand for biologic drugs like monoclonal antibodies and vaccines, is a primary driver. Biologic drugs are increasingly used in treating various diseases, necessitating the production of recombinant proteins, which these services provide. Research and development activities in life sciences and biotechnology, advancements in genetic engineering, and the outsourcing trend in contract manufacturing further boost demand. The rising prevalence of chronic diseases, the imperative for pandemic preparedness highlighted by COVID-19, and ongoing technological advancements in protein expression and purification techniques contribute to the market's growth. Regulatory approvals, especially in the biopharmaceutical sector, ensure the demand for reliable and compliant manufacturing services. Emerging markets and the customization options service providers offer also play a role.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of recombinant proteins manufacturing services. The growth and trends of recombinant proteins manufacturing services industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the recombinant proteins manufacturing services market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Service Type

  • Pre-Clinical & Clinical Services
  • Commercial Production Services

By Host Cell

  • Mammalian Cells
  • Bacterial Cells
  • Insect Cells
  • Yeast & Fungi
  • Others

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Recombinant Proteins Manufacturing Services market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Recombinant Proteins Manufacturing Services market include Lonza, Boehringer Ingelheim International GmbH, FUJIFILM Diosynth Biotechnologies, Merck KGaA, Bruker (InVivo BioTech Services GmbH), Sino Biological, Inc., GenScript, Kaneka Corporation (Kaneka Eurogentec S.A), Polyplus Transfection (Xpress Biologics), Boster Biological Technology, Trenzyme GmbH. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . RECOMBINANT PROTEINS MANUFACTURING SERVICES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Service Type
    • 3.7.2 Market Attractiveness Analysis By Host Cell
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY SERVICE TYPE

  • 5.1 Overview by Service Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Service Type
  • 5.4 Pre-Clinical & Clinical Services Historic and Forecast Sales by Regions
  • 5.5 Commercial Production Services Historic and Forecast Sales by Regions

6 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY HOST CELL

  • 6.1 Overview by Host Cell
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Host Cell
  • 6.4 Mammalian Cells Historic and Forecast Sales by Regions
  • 6.5 Bacterial Cells Historic and Forecast Sales by Regions
  • 6.6 Insect Cells Historic and Forecast Sales by Regions
  • 6.7 Yeast & Fungi Historic and Forecast Sales by Regions
  • 6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-User
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-User
  • 7.4 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
  • 7.5 Academic & Research Institutes Historic and Forecast Sales by Regions

8 . GLOBAL RECOMBINANT PROTEINS MANUFACTURING SERVICES MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE RECOMBINANT PROTEINS MANUFACTURING SERVICES COMPANIES

  • 9.1. Recombinant Proteins Manufacturing Services Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF RECOMBINANT PROTEINS MANUFACTURING SERVICES INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Lonza
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Boehringer Ingelheim International GmbH
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. FUJIFILM Diosynth Biotechnologies
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments
  • 10.6. Merck KGaA
    • 10.6.1. Company Overview
    • 10.6.2. Company Revenue
    • 10.6.3. Products
    • 10.6.4. Recent Developments
  • 10.7. Bruker (InVivo BioTech Services GmbH)
    • 10.7.1. Company Overview
    • 10.7.2. Company Revenue
    • 10.7.3. Products
    • 10.7.4. Recent Developments
  • 10.8. Sino Biological Inc.
    • 10.8.1. Company Overview
    • 10.8.2. Company Revenue
    • 10.8.3. Products
    • 10.8.4. Recent Developments
  • 10.9. GenScript
    • 10.9.1. Company Overview
    • 10.9.2. Company Revenue
    • 10.9.3. Products
    • 10.9.4. Recent Developments
  • 10.10. Kaneka Corporation (Kaneka Eurogentec S.A)
    • 10.10.1. Company Overview
    • 10.10.2. Company Revenue
    • 10.10.3. Products
    • 10.10.4. Recent Developments
  • 10.11. Polyplus Transfection (Xpress Biologics)
    • 10.11.1. Company Overview
    • 10.11.2. Company Revenue
    • 10.11.3. Products
    • 10.11.4. Recent Developments
  • 10.12. Boster Biological Technology
    • 10.12.1. Company Overview
    • 10.12.2. Company Revenue
    • 10.12.3. Products
    • 10.12.4. Recent Developments
  • 10.13. Trenzyme GmbH
    • 10.13.1. Company Overview
    • 10.13.2. Company Revenue
    • 10.13.3. Products
    • 10.13.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies